↓ Skip to main content

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

Overview of attention for article published in Journal of Hematology & Oncology, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
7 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
102 Dimensions

Readers on

mendeley
129 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
Published in
Journal of Hematology & Oncology, December 2020
DOI 10.1186/s13045-020-01007-9
Pubmed ID
Authors

Arnold Bolomsky, Meike Vogler, Murat Cem Köse, Caroline A. Heckman, Grégory Ehx, Heinz Ludwig, Jo Caers

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 129 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 129 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 16%
Student > Master 12 9%
Researcher 11 9%
Student > Bachelor 7 5%
Student > Doctoral Student 5 4%
Other 13 10%
Unknown 60 47%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 34 26%
Medicine and Dentistry 9 7%
Agricultural and Biological Sciences 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Chemistry 3 2%
Other 8 6%
Unknown 65 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2021.
All research outputs
#5,266,281
of 25,837,817 outputs
Outputs from Journal of Hematology & Oncology
#443
of 1,307 outputs
Outputs of similar age
#133,227
of 529,687 outputs
Outputs of similar age from Journal of Hematology & Oncology
#23
of 47 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,307 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.5. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,687 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 47 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.